| Metric | Value (₹ Cr) |
|---|---|
| Revenue | 24.51 |
| Total Income | 24.61 |
| Expenditure | 19.65 |
| PBT | 4.96 |
| Net Profit | 3.63 |
| OPM | 26.73% |
| NPM | 14.75% |
| EPS | 0.59 |
Gaudium IVF Announces Q3 & 9M FY26 Financial Results, Raises ₹1,650.098 Crore in IPO
19 Mar 2026 · 19 Mar, 3:50 pm
Summary
Gaudium IVF and Women Health Limited reported financial updates for Q3 & 9M FY26.
Key Highlights
- 1
rev: 2,450.70
- 2
pbt: 496.31
- 3
pat: 363.05
Management Comments
Dr. Manika Khanna
This is not just a quarter of strong performance, it reflects a category that is coming of age, and Gaudium IVF is at the forefront of shaping it. Our listing marks a structural shift, from building a trusted clinical brand to institutionalising a scalable, future-ready healthcare platform. We have been deliberate in how ygaudium IVF we grow, combining clinical excellence with operational discipline. The opportunity in fertility care in India is significantly underpenetrated, and we see ourselves not just participating in this growth but leading it. Our focus is clear, expand access, deepen outcomes, and build India’s most trusted and outcome-driven fertility network.
Informational and educational content only. Not investment advice.